Specializing In
- Hepatitis B Treatment
- Hepatitis C Treatment
- Hepatology (Liver Conditions)
- Liver Disease Prevention
- Liver Disease Testing
- Liver Transplant
- Polycystic Liver Disease
- Screening Colonoscopy
- Upper GI endoscopy
Biography
Dr. Kwong is a hepatologist who specializes in the care of patients with chronic liver disease. Her clinical and research interests include cirrhosis, alcohol-associated liver disease, portal hypertension, and outcomes before and after liver transplantation.
View Full Biography
Professional Summary
Education & Certifications
- Board Certification, American Board of Preventive Medicine, Addiction Medicine (2025)
- Board Certification: American Board of Internal Medicine, Transplant Hepatology (2020)
- Fellowship, University of California, San Francisco, Advanced/Transplant Hepatology
-
- Fellowship, Stanford University, Gastroenterology and Hepatology
- MS, Stanford University, Epidemiology and Clinical Research
- Residency, University of California, San Francisco, Internal Medicine
- MD, Mount Sinai School of Medicine
- AB, Brown University, Classics-Latin
- ScB, Brown University, Biochemistry and Molecular Biology
Honors & Awards
- Alpha Omega Alpha Honor Society, Mount Sinai School of Medicine (2012)
- Clinical, Translational, and Outcomes Research Award (CTORA), AASLD Foundation (2020-2022)
- Distinction in Research, Mount Sinai School of Medicine (2012)
-
- Emerging Liver Scholar (ELS), American Association for the Study of Liver Diseases (AASLD) (2012)
- ILTS Congress Travel Award, International Liver Transplantation Society (ILTS) (2018)
- KL2 Mentored Career Development Award, Stanford Spectrum (CTSA), National Institutes of Health (NCATS) (2017-2018)
- Liver and Intestinal Community of Practice (LICOP) Travel Grant, American Society of Transplantation (AST) (2018)
- NIAAA K23 Mentored Patient-Oriented Research Career Development Award, National Institutes of Health (2021-2026)
- Young Investigator Abstract Travel Award, AASLD Foundation (2017)
- Young Investigator Travel Bursary, European Association for the Study of Liver Diseases (EASL) (2017)
Memberships
- Chair, Liver Transplantation and Surgery Special Interest Group, American Association for the Study of Liver Diseases (AASLD) (2026 - Present)
- Clinical Chair, AST Scientific Review Committee, American Society of Transplantation (2026 - Present)
- Clinical Research Committee, American Association for the Study of Liver Diseases (AASLD) (2023 - 2025)
-
- Associate Editor, American Journal of Transplantation (2022 - Present)
- At-Large Representatative, OPTN Liver and Intestine Committee (2021 - Present)
- Board Member, Northern California Society for Clinical Gastroenterology (NCSCG) (2021 - Present)
- Editorial Board, Liver Transplantation (2021 - 2023)
- At-Large Steering Committee Member, Public Health / Health Care Delivery Special Interest Group, American Association for the Study of Liver Diseases (AASLD) (2020 - 2022)
- Member, European Association for the Study of Liver Diseases (EASL) (2017 - Present)
- Member, American Society of Transplantation (AST) (2015 - Present)
- Member, American Association for the Study of Liver Diseases (AASLD) (2009 - Present)
Publications
-
Downregulation of Hepatic Stellate Cell Activation by Retinol and Palmitate Mediated by Adipose Differentiation-Related Protein (ADRP)
Lee, T. F., Mak, K. M., Rackovsky, O., Lin, Y.-L., Kwong, A. J., Loke, J. C., & Friedman, S. L. (2010). Downregulation of Hepatic Stellate Cell Activation by Retinol and Palmitate Mediated by Adipose Differentiation-Related Protein (ADRP). JOURNAL OF CELLULAR PHYSIOLOGY, 223(3), 648–657. -
Hepatic Steatosis, Fibrosis, and Cancer in Elderly Cadavers
Mak, K. M., Kwong, A. J., Chu, E., & Hoo, N. M. (2012). Hepatic Steatosis, Fibrosis, and Cancer in Elderly Cadavers. ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 295(1), 40–50. -
Liver Fibrosis in Elderly Cadavers: Localization of Collagen Types I, III, and IV, alpha-Smooth Muscle Actin, and Elastic Fibers
Mak, K. M., Chu, E., Lau, K. H. V., & Kwong, A. J. (2012). Liver Fibrosis in Elderly Cadavers: Localization of Collagen Types I, III, and IV, alpha-Smooth Muscle Actin, and Elastic Fibers. ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 295(7), 1159–1167. -
-
Does it matter what day of the week you have your colonoscopy?
Kwong, A. J., Eaton, E. E., Cohen, L. B., Miller, K. M., & Aisenberg, J. A. (2012). Does it matter what day of the week you have your colonoscopy? Gastrointestinal Endoscopy, 76(3), 700–702. -
Reduced Hepatic Stellate Cell Expression of Kruppel-Like Factor 6 Tumor Suppressor Isoforms Amplifies Fibrosis During Acute and Chronic Rodent Liver Injury
Ghiassi-nejad, Z., Hernandez-Gea, V., Woodrell, C., Lang, U. E., Dumic, K., Kwong, A., & Friedman, S. L. (2013). Reduced Hepatic Stellate Cell Expression of Kruppel-Like Factor 6 Tumor Suppressor Isoforms Amplifies Fibrosis During Acute and Chronic Rodent Liver Injury. HEPATOLOGY, 57(2), 786–796. -
Update on the management of the liver transplant patient
Kwong, A. J., & Fix, O. K. (2015). Update on the management of the liver transplant patient. CURRENT OPINION IN GASTROENTEROLOGY, 31(3), 224–32. -
Outcomes for liver transplant candidates listed with low model for end-stage liver disease score
Kwong, A. J., Lai, J. C., Dodge, J. L., & Roberts, J. P. (2015). Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. LIVER TRANSPLANTATION, 21(11), 1403–9. -
Evaluation of a Resident-Led Project to Decrease Phlebotomy Rates in the Hospital: Think Twice, Stick Once
Wheeler, D., Marcus, P., Nguyen, J., Kwong, A., Khaki, A. R., Valencia, V., & Moriates, C. (2016). Evaluation of a Resident-Led Project to Decrease Phlebotomy Rates in the Hospital: Think Twice, Stick Once. JAMA INTERNAL MEDICINE, 176(5), 708–710. -
Improved Post-Transplant Mortality After Share 35 for Liver Transplantation.
Kwong, A. J., Goel, A., Mannalithara, A., & Kim, W. R. (2017). Improved Post-Transplant Mortality After Share 35 for Liver Transplantation. Hepatology (Baltimore, Md.). -
Decreasing Mortality and Disease Severity in Hepatitis C Patients Awaiting Liver Transplantation in the United States.
Kwong, A., Kim, W. R., Mannalithara, A., Heo, N.-Y. Y., Udompap, P., & Kim, D. (2017). Decreasing Mortality and Disease Severity in Hepatitis C Patients Awaiting Liver Transplantation in the United States. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Artificial Neural Networks and liver transplantation: Are we ready for self-driving cars?
Kwong, A. J., & Asrani, S. K. (2017). Artificial Neural Networks and liver transplantation: Are we ready for self-driving cars? Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
Wei, M., Ford, J., Li, Q., Jeong, D., Kwong, A. J., Nguyen, M. H., & Chang, M. S. (2018). Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California. Digestive Diseases and Sciences. -
Peripartum Care for Mothers Diagnosed with Hepatitis B During Pregnancy: A Survey of Provider Practices.
Kwong, A. J., Chang, M. S., Tuomala, R. E., Riley, L. E., Robinson, J. N., Mutinga, M. L., … Rutherford, A. E. (2018). Peripartum Care for Mothers Diagnosed with Hepatitis B During Pregnancy: A Survey of Provider Practices. Maternal and Child Health Journal. -
De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
Kwong, A. J., Kim, W. R., & Flemming, J. A. (2018). De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era. Hepatology (Baltimore, Md.). -
Risk Prediction Models for Graft Failure after Liver Transplantation: A Machine-Learning Approach
Kwong, A. J., O'Connell, C., Kanzawa, M., Hufker, K., Lindsay, N., & Kim, W. R. (2018). Risk Prediction Models for Graft Failure after Liver Transplantation: A Machine-Learning Approach. HEPATOLOGY, 68, 668A–669A. -
Prediction of Mortality Risk in Decompensated Cirrhosis Due to Primary Biliary Cholangitis
Kwong, A. J., Goel, A., Mannalithara, A., Iloeje, U., Feng, C., & Kim, W. R. (2018). Prediction of Mortality Risk in Decompensated Cirrhosis Due to Primary Biliary Cholangitis. HEPATOLOGY, 68, 1098A–1099A. -
Liver Transplantation for HCV Non-Viremic Recipients with HCV Viremic Donors.
Kwong, A. J., Wall, A., Melcher, M., Wang, U., Ahmed, A., Subramanian, A., & Kwo, P. Y. (2018). Liver Transplantation for HCV Non-Viremic Recipients with HCV Viremic Donors. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancer.
Wong, K., Ozeki, K., Kwong, A., Patel, B. N., & Kwo, P. (2018). The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancer. PloS One, 13(12), e0208233. -
Migration of Patients for Liver Transplantation and Waitlist Outcomes.
Kwong, A. J., Mannalithara, A., Heimbach, J., Prentice, M. A., & Kim, W. R. (2019). Migration of Patients for Liver Transplantation and Waitlist Outcomes. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. -
Trends in Endoscopic Mucosal Resection for Nonmalignant Colorectal Polyps in the United States.
Yu, J. X., Lin, J. L., Oliver, M., Soetikno, R., Chang, M. S., Kwong, A. J., … Kaltenbach, T. (2019). Trends in Endoscopic Mucosal Resection for Nonmalignant Colorectal Polyps in the United States. Gastrointestinal Endoscopy. -
Reply to: "The decreasing predictive power of MELD in an era of changing etiology of liver disease".
Kwong, A., Mannalithara, A., & Kim, W. R. (2019). Reply to: "The decreasing predictive power of MELD in an era of changing etiology of liver disease". American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
OPTN/SRTR 2018 Annual Data Report: Liver.
Kwong, A., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., … Kasiske, B. L. (2020). OPTN/SRTR 2018 Annual Data Report: Liver. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 20 Suppl s1, 193–299. -
Editorial: glecaprevir/pibrentasvir for the treatment of hepatitis C virus-do baseline resistance-associated substitutions matter?
Kwong, A. J., & Kwo, P. Y. (2020). Editorial: glecaprevir/pibrentasvir for the treatment of hepatitis C virus-do baseline resistance-associated substitutions matter? Alimentary Pharmacology & Therapeutics, 51(7), 739–40. -
Center variation in intention to treat survival among patients listed for liver transplant.
Kwong, A. J., Flores, A., Saracino, G., Boutte, J., McKenna, G., Giuliano, T., … Asrani, S. K. (2020). Center variation in intention to treat survival among patients listed for liver transplant. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium.
Kwong, A. J., Devuni, D., Wang, C., Boike, J., Jo, J., VanWagner, L., … Goel, A. (2020). Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients with Chronic Hepatitis B.
Sripongpun, P., Kim, W. R., Mannalithara, A., Kwong, A., Daugherty, T., Goel, A., & Kwo, P. Y. (2020). Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients with Chronic Hepatitis B. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. -
Expanding the Limits of Liver Transplantation for Hepatocellular Carcinoma Is There a Limit?
Kwong, A., & Mehta, N. (2021). Expanding the Limits of Liver Transplantation for Hepatocellular Carcinoma Is There a Limit? CLINICS IN LIVER DISEASE, 25(1), 19–33. -
Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation
Alshuwaykh, O., Kwong, A., Goel, A., Cheung, A., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2020). Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. HEPATOLOGY COMMUNICATIONS. -
OPTN/SRTR 2019 Annual Data Report: Liver.
Kwong, A. J., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., … Kasiske, B. L. (2021). OPTN/SRTR 2019 Annual Data Report: Liver. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21 Suppl 2, 208–315. -
Predicting survival after liver transplant: A noble pursuit or a fool's errand?
Kwong, A. J., & Kim, W. R. (2021). Predicting survival after liver transplant: A noble pursuit or a fool's errand? Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome.
Kwong, A., Kim, W. R., Kwo, P. Y., Wang, U., & Cheng, X. (2021). Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Preliminary Evidence for a Relationship between Elevated Plasma TNF alpha and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity
Zahr, N. M., Pohl, K. M., Kwong, A. J., Sullivan, E. V., & Pfefferbaum, A. (2021). Preliminary Evidence for a Relationship between Elevated Plasma TNF alpha and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(9). -
National Trends and Waitlist Outcomes of Locoregional Therapy among Liver Transplant Candidates with Hepatocellular Carcinoma in the United States.
Kwong, A. J., Ghaziani, T. T., Yao, F., Sze, D., Mannalithara, A., & Mehta, N. (2021). National Trends and Waitlist Outcomes of Locoregional Therapy among Liver Transplant Candidates with Hepatocellular Carcinoma in the United States. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. -
Correcting the sex disparity in access to liver transplantation - Lest perfect be the enemy of better.
Kwong, A. J., Lai, J. C., & Kim, W. R. (2021). Correcting the sex disparity in access to liver transplantation - Lest perfect be the enemy of better. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era.
Kim, W. R., Mannalithara, A., Heimbach, J. K., Kamath, P. S., Asrani, S. K., Biggins, S. W., … Kwong, A. J. (2021). MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era. Gastroenterology. -
Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.
Singal, A. K., Kwo, P., Kwong, A., Liangpunsakul, S., Louvet, A., Mandrekar, P., … Shah, V. H. (2021). Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease. Hepatology (Baltimore, Md.). -
Decreased urgency among liver transplant candidates with hepatocellular carcinoma in the United States.
Kwong, A. J., Ghaziani, T. T., & Mehta, N. (2021). Decreased urgency among liver transplant candidates with hepatocellular carcinoma in the United States. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Machine learning to predict waitlist dropout among liver transplant candidates with hepatocellular carcinoma.
Kwong, A., Hameed, B., Syed, S., Ho, R., Mard, H., Arshad, S., … Mehta, N. (1800). Machine learning to predict waitlist dropout among liver transplant candidates with hepatocellular carcinoma. Cancer Medicine. -
Author response to "MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era".
Kwong, A., & Kim, W. R. (1800). Author response to "MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era". Gastroenterology. -
The steatosis-associated fibrosis estimator (SAFE) score: A tool to detect low-risk non-alcoholic fatty liver disease in primary care.
Sripongpun, P., Kim, W. R., Mannalithara, A., Charu, V., Vidovszky, A., Asch, S., … Kwong, A. J. (2022). The steatosis-associated fibrosis estimator (SAFE) score: A tool to detect low-risk non-alcoholic fatty liver disease in primary care. Hepatology (Baltimore, Md.). -
CAQ Corner: Disease Recurrence After Liver Transplantation.
Goel, A., & Kwong, A. (2022). CAQ Corner: Disease Recurrence After Liver Transplantation. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
"Beyond MELD" - Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation.
Ge, J., Kim, W. R., Lai, J. C., & Kwong, A. J. (2022). "Beyond MELD" - Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation. Journal of Hepatology, 76(6), 1318–1329. -
Heterogeneity in Center Practices in Liver Transplantation for Alcohol-associated Liver Disease in the United States.
Lim, N., Kwong, A. J., Jafri, S.-M., Jesse, M. T., Kriss, M., Nair, K., … Desai, A. P. (2022). Heterogeneity in Center Practices in Liver Transplantation for Alcohol-associated Liver Disease in the United States. The American Journal of Gastroenterology. -
Liver allocation policies for hepatocellular carcinoma have leveled the playing field - but who should be playing?
Kwong, A. J., & Mehta, N. (2022). Liver allocation policies for hepatocellular carcinoma have leveled the playing field - but who should be playing? Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy.
Alshuwaykh, O., Daugherty, T., Cheung, A., Goel, A., Dhanasekaran, R., Ghaziani, T. T., … Kwo, P. Y. (2022). Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy. Hepatology Communications. -
Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome.
Kwong, A. J., Kim, W. R., Lake, J., Stock, P. G., Wang, C. J., Wetmore, J. B., … Israni, A. K. (2022). Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome. Transplantation. -
Mortality in End Stage Liver Patients Above MELD 3.0 of 40.
Tarlow, B. D., Kim, W. R., Mannalithara, A., Kwo, P. Y., Bonham, C. A., & Kwong, A. (2022). Mortality in End Stage Liver Patients Above MELD 3.0 of 40. Hepatology (Baltimore, Md.). -
Assessment of Donor quality and risk of graft failure after liver transplantation: The ID2 EAL score.
Asrani, S. K., Saracino, G., Wall, A., Trotter, J. F., Testa, G., Hernaez, R., … McKenna, G. (2022). Assessment of Donor quality and risk of graft failure after liver transplantation: The ID2 EAL score. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites.
Alshuwaykh, O., Cheung, A., Goel, A., Kwong, A., Dhanasekaran, R., Ghaziani, T. T., … Kwo, P. Y. (2022). Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites. BMC Gastroenterology, 22(1), 410. -
Reevaluating Liver Donor Risk in the Era of Improved Hepatitis C Virus Treatment.
Handley, T. J., Arnow, K., Sasaki, K., Kwong, A., & Melcher, M. L. (2022). Reevaluating Liver Donor Risk in the Era of Improved Hepatitis C Virus Treatment. JAMA Surgery. -
Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant Candidates.
Wu, X., Heller, M., Kwong, A., Fidelman, N., & Mehta, N. (2023). Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant Candidates. Journal of Vascular and Interventional Radiology : JVIR. -
Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation.
Snyder, A., Kojima, L., Imaoka, Y., Akabane, M., Kwong, A., Melcher, M. L., & Sasaki, K. (2023). Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Serum biomarkers of liver fibrosis identify globus pallidus vulnerability.
Kwong, A. J., & Zahr, N. M. (2023). Serum biomarkers of liver fibrosis identify globus pallidus vulnerability. NeuroImage. Clinical, 37, 103333. -
MELD 3.0 for adolescent liver transplant candidates.
Kwong, A. J., Zhang, K.-Y. Y., Ebel, N., Mannalithara, A., & Kim, W. R. (2023). MELD 3.0 for adolescent liver transplant candidates. Hepatology (Baltimore, Md.). -
OPTN/SRTR 2021 Annual Data Report: Liver.
Kwong, A. J., Ebel, N. H., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., … Kasiske, B. L. (2023). OPTN/SRTR 2021 Annual Data Report: Liver. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 23(2S1), S178–S263. -
One size does not fit all: Differential benefits of simultaneous liver-kidney transplantation by eligibility criteria.
Cheng, X. S., McElroy, L. M., Sanoff, S. L., & Kwong, A. J. (2023). One size does not fit all: Differential benefits of simultaneous liver-kidney transplantation by eligibility criteria. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Optimizing liver transplant prioritization for hepatocellular carcinoma through risk stratification.
Norman, J., Mehta, N., & Kwong, A. (2023). Optimizing liver transplant prioritization for hepatocellular carcinoma through risk stratification. Current Opinion in Organ Transplantation. -
Decreased Utilization Rate of Grafts for Liver Transplantation After Implementation of Acuity Circle-based Allocation.
Bekki, Y., Myers, B., Tomiyama, K., Imaoka, Y., Akabane, M., Kwong, A. J., … Sasaki, K. (2023). Decreased Utilization Rate of Grafts for Liver Transplantation After Implementation of Acuity Circle-based Allocation. Transplantation. -
Overcoming the hurdles of steatotic grafts in liver transplantation: insights into survival and prognostic factors.
Akabane, M., Imaoka, Y., Esquivel, C. O., Melcher, M. L., Kwong, A., & Sasaki, K. (2023). Overcoming the hurdles of steatotic grafts in liver transplantation: insights into survival and prognostic factors. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Implementation of a national liver review board for exception requests in the united states: A two-year monitoring report.
Kwong, A. J., Foutz, J., Cafarella, M., Biggins, S. W., Shah, N. D., Eason, J., … Trotter, J. (2023). Implementation of a national liver review board for exception requests in the united states: A two-year monitoring report. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of hepatocellular carcinoma before liver transplant.
Wu, X., Kwong, A., Heller, M., Lokken, R. P., Fidelman, N., & Mehta, N. (2023). Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of hepatocellular carcinoma before liver transplant. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Hepatitis C Screening in Post-Baby Boomer Generation Americans: One Size Does Not Fit All.
Sripongpun, P., Udompap, P., Mannalithara, A., Downing, N. L., Vidovszky, A. A., Kwong, A. J., … Kim, W. R. (2023). Hepatitis C Screening in Post-Baby Boomer Generation Americans: One Size Does Not Fit All. Mayo Clinic Proceedings, 98(9), 1335–1344. -
Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models.
Sedki, M., Kwong, A., Bhargava, M., Ahmed, A., Daugherty, T., Kwo, P., … Goel, A. (2023). Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models. Transplantation. -
Introducing W. Ray Kim, MD, Our 2024 AASLD president
Lim, Y.-S., Kwong, A., & Allen, A. M. (2023). Introducing W. Ray Kim, MD, Our 2024 AASLD president. HEPATOLOGY. -
Summary of a Consensus Conference on Heart-Liver Transplantation.
Kobashigawa, J., VanWagner, L. B., Hall, S., Emamaullee, J., Entwistle, J. W., Ganger, D., … Shingina, A. (2023). Summary of a Consensus Conference on Heart-Liver Transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
Introducing W. Ray Kim, MD, our 2024 AASLD president.
Lim, Y.-S. S., Kwong, A. J., & Allen, A. M. (2024). Introducing W. Ray Kim, MD, our 2024 AASLD president. Hepatology (Baltimore, Md.), 79(1), 21–24. -
LIVER VOLUME PREDICTS MORTALITY IN ALCOHOL ASSOCIATED LIVER DISEASE
Manikat, R., Wu, W., Kwo, P. Y., Kothary, N., Chaudhari, A., & Kwong, A. J. (2023). LIVER VOLUME PREDICTS MORTALITY IN ALCOHOL ASSOCIATED LIVER DISEASE. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Liver transplant activity for alcohol associated hepatitis after OPTN diagnosis updates.
Folta, K., Chung, N., Biggins, S. W., & Kwong, A. J. (2024). Liver transplant activity for alcohol associated hepatitis after OPTN diagnosis updates. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Management of ascites and volume overload in patients with cirrhosis.
Kwong, A. J., Norman, J., & Biggins, S. W. (2024). Management of ascites and volume overload in patients with cirrhosis. Clinical Liver Disease, 23(1), e0115. -
Excess waitlist mortality among candidates for multivisceral liver-intestine transplant in acuity circle allocation.
Kwong, A. J., Schnellinger, E., Foutz, J., Cafarella, M., Nagai, S., Biggins, S. W., … Trotter, J. (2024). Excess waitlist mortality among candidates for multivisceral liver-intestine transplant in acuity circle allocation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
OPTN/SRTR 2022 Annual Data Report: Liver.
Kwong, A. J., Kim, W. R., Lake, J. R., Schladt, D. P., Schnellinger, E. M., Gauntt, K., … Israni, A. K. (2024). OPTN/SRTR 2022 Annual Data Report: Liver. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 24(2S1), S176–S265. -
Benchmarking clinical risk prediction algorithms with ensemble machine learning for the non-invasive diagnosis of liver fibrosis in NAFLD.
Charu, V., Liang, J. W., Mannalithara, A., Kwong, A., Tian, L., & Kim, W. R. (2024). Benchmarking clinical risk prediction algorithms with ensemble machine learning for the non-invasive diagnosis of liver fibrosis in NAFLD. Hepatology (Baltimore, Md.). -
Longer Term Follow-up on Acuity Circle Allocation Strategies in Liver Transplantation
Kwong, A. J., Jowell, A., Bambha, K., & Biggins, S. W. (2024). Longer Term Follow-up on Acuity Circle Allocation Strategies in Liver Transplantation. CURRENT TRANSPLANTATION REPORTS. -
Continuous Risk Score Predicts Waitlist & Post-Transplant Outcomes in Hepatocellular Carcinoma Despite Exception Changes.
Akabane, M., McVey, J. C., Firl, D. J., Kwong, A. J., Melcher, M. L., Kim, W. R., & Sasaki, K. (2024). Continuous Risk Score Predicts Waitlist & Post-Transplant Outcomes in Hepatocellular Carcinoma Despite Exception Changes. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. -
Common Definitions and Variables are Needed for the United States to Join the Conversation on Acute on Chronic Liver Failure.
Ge, J., Kim, W. R., & Kwong, A. J. (2024). Common Definitions and Variables are Needed for the United States to Join the Conversation on Acute on Chronic Liver Failure. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
Principles for simulating the organ allocation system
Wood, N. L., Weaver, T., Kwong, A. J., & Gentry, S. E. (2024). Principles for simulating the organ allocation system. LIVER TRANSPLANTATION. -
Disparities in liver transplantation: One size may not fit all.
Kwong, A. J., Allen, A. M., & Heimbach, J. (2024). Disparities in liver transplantation: One size may not fit all. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
Psychosocial predictors of return to alcohol use after liver transplant: A multicenter cohort study.
Torosian, K., Shahrvini, B., Johnson, W. M., Vodkin, I., Tincopa, M., Lim, N., … Ajmera, V. (2024). Psychosocial predictors of return to alcohol use after liver transplant: A multicenter cohort study. Alcohol, Clinical & Experimental Research. -
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type.
Akabane, M., Bekki, Y., Inaba, Y., Imaoka, Y., Esquivel, C. O., Kwong, A., … Sasaki, K. (2024). Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Association of Non-Standardized MELD Score Exceptions with Waitlist Mortality in Adult Liver Transplant Candidates.
Ahn, D. J., Kwong, A. J., Wall, A. E., & Parker, W. F. (2024). Association of Non-Standardized MELD Score Exceptions with Waitlist Mortality in Adult Liver Transplant Candidates. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
Beyond 75: Graft Allocation and Organ Utility Implications in Liver Transplantation.
Akabane, M., Kwong, A., Imaoka, Y., Esquivel, C. O., Kim, W. R., Melcher, M. L., & Sasaki, K. (2024). Beyond 75: Graft Allocation and Organ Utility Implications in Liver Transplantation. Transplantation Direct, 10(10), e1661. -
Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study.
Hu, K., Sedki, M., Kwong, A., Kesselman, A., Kolli, K. P., Morelli, G., … Goel, A. (2024). Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Alimentary Pharmacology & Therapeutics. -
YTTRIUM-90 RADIOEMBOLIZATION HAS BECOME THE MOST UTILIZED BRIDGING TREATMENT FOR LIVER TRANSPLANT CANDIDATES IN THE UNITED STATES.
Salem, R., Kwong, A. J., Kim, N., Sze, D. Y., & Mehta, N. (2024). YTTRIUM-90 RADIOEMBOLIZATION HAS BECOME THE MOST UTILIZED BRIDGING TREATMENT FOR LIVER TRANSPLANT CANDIDATES IN THE UNITED STATES. Journal of Vascular and Interventional Radiology : JVIR. -
Multi-HCC: A practical model to prioritize patients with hepatocellular carcinoma on the liver transplant waiting list.
Norman, J., Mehta, N., Kim, W. R., Liang, J. W., Biggins, S. W., Asrani, S. K., … Kwong, A. J. (2024). Multi-HCC: A practical model to prioritize patients with hepatocellular carcinoma on the liver transplant waiting list. Gastroenterology. -
Results of a phase 2b multicenter randomized trial of larsucosterol for the treatment of severe alcohol-associated hepatitis (AHFIRM trial)
Shiffman, M., Ben Da, Stein, L., Moreno, C., Mehta, A., Louvet, A., … Sussman, N. (2024). Results of a phase 2b multicenter randomized trial of larsucosterol for the treatment of severe alcohol-associated hepatitis (AHFIRM trial). JOURNAL OF HEPATOLOGY. ELSEVIER. -
Hepatitis C-positive grafts for hepatitis C-negative recipients in liver transplantation: Buried treasure or depleting resource?
Nakayama, T., Krist, D. T., Akabane, M., Imaoka, Y., Esquivel, C. O., Kwong, A. J., … Sasaki, K. (2024). Hepatitis C-positive grafts for hepatitis C-negative recipients in liver transplantation: Buried treasure or depleting resource? Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Optimal population screening strategies for liver fibrosis associated with metabolic dysfunction-associated steatotic liver disease.
Kim, W. R., Mannalithara, A., Charu, V., Chung, N., Kwong, A., Kwo, P. Y., … Kim, S. H. (2025). Optimal population screening strategies for liver fibrosis associated with metabolic dysfunction-associated steatotic liver disease. The American Journal of Gastroenterology. -
AHEAD, A NOVEL VALIDATED MACHINE LEARNING MODEL FOR CLINICAL DIAGNOSIS OF ALCOHOL-ASSOCIATED HEPATITIS
Ismail, A., Dunn, W., Im, G., Weinberg, E., Kwong, A., Clemente, A., … Singal, A. (2024). AHEAD, A NOVEL VALIDATED MACHINE LEARNING MODEL FOR CLINICAL DIAGNOSIS OF ALCOHOL-ASSOCIATED HEPATITIS. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
ALCOHOL USE DISORDER TREATMENT DURING EVALUATION IN PATIENTS WITH ALD REFERRED FOR EARLY LIVER TRANSPLANT
Wang, K., Deutsch-Link, S., Wu, W., Kwong, A., Mohamed, K., Lim, N., … Shroff, H. (2024). ALCOHOL USE DISORDER TREATMENT DURING EVALUATION IN PATIENTS WITH ALD REFERRED FOR EARLY LIVER TRANSPLANT. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
PREDICTORS OF SURVIVAL AND HEPATIC RECOMPENSATION IN PATIENTS WITH ALD REFERRED FOR EARLY LIVER TRANSPLANTATION
Lim, N., Roldan, G., Mohamed, K., Wu, W., Judge, G., Cooper, K., … Kwong, A. (2024). PREDICTORS OF SURVIVAL AND HEPATIC RECOMPENSATION IN PATIENTS WITH ALD REFERRED FOR EARLY LIVER TRANSPLANTATION. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
GENDER DISPARITIES IN LISTING AND TRANSPLANTATION IN PATIENTS WITH ALD REFERRED FOR EARLY LIVER TRANSPLANTATION
Cooper, K., Colletta, A., Patel, A., Mohamed, K., Lim, N., Wu, W., … Devuni, D. (2024). GENDER DISPARITIES IN LISTING AND TRANSPLANTATION IN PATIENTS WITH ALD REFERRED FOR EARLY LIVER TRANSPLANTATION. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
POPULATION BASED SCREENING FOR ALCOHOL ASSOCIATED LIVER DISEASE USING THE ELECTRONIC HEALTH RECORD
Folta, K., Mendelson, J., Prochaska, J., Hallgren, K., Wu, W., & Kwong, A. (2024). POPULATION BASED SCREENING FOR ALCOHOL ASSOCIATED LIVER DISEASE USING THE ELECTRONIC HEALTH RECORD. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
HUMAN VERSUS ARTIFICIAL INTELLIGENCE: HEAD-TO-HEAD COMPARISON OF PREDICTIVE
Charu, V., Liang, J., Mannalithara, A., Kwong, A., & Kim, W. R. (2024). HUMAN VERSUS ARTIFICIAL INTELLIGENCE: HEAD-TO-HEAD COMPARISON OF PREDICTIVE. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
DRINKING BEHAVIOR IN THE AHFIRM TRIAL AS MEASURED BY PHOSPHATIDYL ETHANOL
Flamm, S., Shiffman, M., Goel, A., Kwong, A., Stein, L., Mehta, A., … Ellis, D. (2024). DRINKING BEHAVIOR IN THE AHFIRM TRIAL AS MEASURED BY PHOSPHATIDYL ETHANOL. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
A BALANCING ACT: THE LIFE-SAVING POTENTIAL AND DILEMMA OF LIVER TRANSPLANTATION AS AN ENDPOINT IN ALCOHOL-ASSOCIATED HEPATITIS TRIALS
Goel, A., Kwong, A., Stein, L., Louvet, A., Satapathy, S., Mehta, A., … Lin, W. Q. (2024). A BALANCING ACT: THE LIFE-SAVING POTENTIAL AND DILEMMA OF LIVER TRANSPLANTATION AS AN ENDPOINT IN ALCOHOL-ASSOCIATED HEPATITIS TRIALS. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
EFFECTS OF TIMELY TREATMENT ON OUTCOMES OF LARSUCOSTEROL FOR SEVERE ALCOHOL-ASSOCIATED HEPATITIS (AHFIRM TRIAL)
Stein, L., Shiffman, M., Goel, A., Kwong, A., Mehta, A., Moreno, C., … Brown, J. (2024). EFFECTS OF TIMELY TREATMENT ON OUTCOMES OF LARSUCOSTEROL FOR SEVERE ALCOHOL-ASSOCIATED HEPATITIS (AHFIRM TRIAL). HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
CALIBRATING EXCEPTION POINTS FOR CONTINUOUS DISTRIBUTION: WHY MATCHING HCC TO NON-HCC WAITLIST DROPOUT FALLS SHORT
Norman, J., Liang, J., Mehta, N., Charu, V., & Kwong, A. (2024). CALIBRATING EXCEPTION POINTS FOR CONTINUOUS DISTRIBUTION: WHY MATCHING HCC TO NON-HCC WAITLIST DROPOUT FALLS SHORT. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
LONGITUDINAL OUTCOMES AND RECOVERY IN PATIENTS WITH DECOMPENSATED ALCOHOL ASSOCIATED LIVER DISEASE
Wu, W., Cavalla, B., Judge, G., & Kwong, A. (2024). LONGITUDINAL OUTCOMES AND RECOVERY IN PATIENTS WITH DECOMPENSATED ALCOHOL ASSOCIATED LIVER DISEASE. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
ROLE OF HIGH VERSUS STANDARD DOSE OF TERLIPRESSIN IN REVERSING HRS- AKI: POOLED ANALYSIS FROM PHASE 3 CLINICAL TRIALS
Sharma, P., Lim, N., Kwong, A., Asrani, S., Biggins, S., Cardoza, S., & Wong, F. (2024). ROLE OF HIGH VERSUS STANDARD DOSE OF TERLIPRESSIN IN REVERSING HRS- AKI: POOLED ANALYSIS FROM PHASE 3 CLINICAL TRIALS. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
VARIABLE TREATMENT AND ACCESS TO LIVER TRANSPLANTATION FOR ALCOHOL ASSOCIATED LIVER DISEASE: THE CALIFORNIA LIVER NETWORK
Jowell, A., Yilma, M., Seneviratne, S., Zhou, K., Wu, W., Singh, J., … Kwong, A. (2024). VARIABLE TREATMENT AND ACCESS TO LIVER TRANSPLANTATION FOR ALCOHOL ASSOCIATED LIVER DISEASE: THE CALIFORNIA LIVER NETWORK. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.
Shiffman, M., Da, B., Goel, A., Kwong, A., Stein, L., Moreno, C., … Lin, W. Q. (2025). Larsucosterol for the Treatment of Alcohol-Associated Hepatitis. NEJM Evidence, 4(2), EVIDoa2400243. -
OPTN/SRTR 2023 Annual Data Report: Liver.
Kwong, A. J., Kim, W. R., Lake, J. R., Schladt, D. P., Handarova, D., Howell, J., … Israni, A. K. (2025). OPTN/SRTR 2023 Annual Data Report: Liver. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 25(2S1), S193–S287. -
Navigating new frontiers: onsite machine perfusion in US liver transplantation.
Akabane, M., Bekki, Y., Kwong, A. J., Esquivel, C. O., Kim, W. R., Melcher, M. L., & Sasaki, K. (2025). Navigating new frontiers: onsite machine perfusion in US liver transplantation. HPB : the Official Journal of the International Hepato Pancreato Biliary Association. -
Perioperative Outcomes of Limited Sobriety Versus Standard Sobriety Liver Transplantation for Alcohol-associated Liver Disease.
Fu, S., Pan, J. H., Kadri, H., Contag, C., Ferguson, J., Sedki, M., … Melcher, M. L. (2025). Perioperative Outcomes of Limited Sobriety Versus Standard Sobriety Liver Transplantation for Alcohol-associated Liver Disease. Transplantation Proceedings. -
PRO MELD: MELD is the best method of prioritization for liver transplantation.
Charu, V., Kim, W. R., & Kwong, A. J. (2025). PRO MELD: MELD is the best method of prioritization for liver transplantation. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
OPTN/SRTR 2023 Annual Data Report Liver
Kwong, A. J., Kim, W. R., Lake, J. R., Schladt, D. P., Handarova, D., Howell, J., … Israni, A. K. (2025). OPTN/SRTR 2023 Annual Data Report Liver. AMERICAN JOURNAL OF TRANSPLANTATION, 25(2), S193–S287. -
The impact of liver transplantation on endpoint selection in alcohol-associated hepatitis trials.
Liangpunsakul, S., Krebs, W. B., Kwong, A. J., Kwo, P. Y., Brown, R. S., Lin, W. Q., & Sussman, N. L. (2025). The impact of liver transplantation on endpoint selection in alcohol-associated hepatitis trials. Hepatology Communications, 9(5). -
Steatotic Liver Disease in the US: The Impact of the New Nomenclature on Classification of Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease
Sedki, M., Kim, W. R., Kwong, A., Charu, V., Sripongpun, P., & Mannalithara, A. (2025). Steatotic Liver Disease in the US: The Impact of the New Nomenclature on Classification of Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease. GASTRO HEP ADVANCES, 4(5). -
Reply to Wang, Jing and Song, and Pan and Zhou.
Charu, V., Kwong, A. J., & Norman, J. S. (2025). Reply to Wang, Jing and Song, and Pan and Zhou. Gastroenterology. -
Changes in the liver transplant evaluation process during the early COVID-19 era and the role of telehealth.
Jowell, A. H., Kwong, A. J., Reguram, R., Daugherty, T. J., & Kwo, P. Y. (2025). Changes in the liver transplant evaluation process during the early COVID-19 era and the role of telehealth. World Journal of Transplantation, 15(2), 99401. -
Steatotic Liver Disease in the US: The Impact of the New Nomenclature on Classification of Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease.
Sedki, M., Kim, W. R., Kwong, A., Charu, V., Sripongpun, P., & Mannalithara, A. (2025). Steatotic Liver Disease in the US: The Impact of the New Nomenclature on Classification of Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease. Gastro Hep Advances, 4(5), 100629. -
"The alcohol-harm paradox": Understanding socioeconomic inequalities in liver disease.
Weichselbaum, L., Kupferman, J., Kwong, A. J., & Moreno, C. (2025). "The alcohol-harm paradox": Understanding socioeconomic inequalities in liver disease. JHEP Reports : Innovation in Hepatology, 7(9), 101480. -
National Trends in Machine Perfusion and Living Donor Liver Transplantation: Complement or Competition?
Meier, R. P., King, E. A., Cameron, A. M., Malik, S., Maluf, D. G., Bhati, C. S., & Kwong, A. (2025). National Trends in Machine Perfusion and Living Donor Liver Transplantation: Complement or Competition? Transplantation. -
Gender disparity in access to early liver transplant among patients with alcohol associated liver disease and limited sobriety is mediated by psychosocial factors.
Cooper, K. M., Patel, A. K., Colletta, A., Mohamed, K., Lim, N., Wu, W., … Devuni, D. (2025). Gender disparity in access to early liver transplant among patients with alcohol associated liver disease and limited sobriety is mediated by psychosocial factors. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. -
Outcomes from Referral to Transplant for Patients with MASLD: A California Liver Network Study.
Lim, T. Y., Steggerda, J. A., Trivedi, H., Luu, M., Vipani, A., Adjei, M. A., … Wisel, S. A. (2025). Outcomes from Referral to Transplant for Patients with MASLD: A California Liver Network Study. Journal of Clinical Medicine, 14(21). -
Role of Social Determinants and Outcomes of Patients with Alcohol-Associated Liver Disease Referred for Early Liver Transplantation: A Multicenter Analysis.
Hasjim, B. J., Rajan, A., Saravanan, N., Wu, W., Kwong, A. J., Mohamed, K., … Cheung, A. (2025). Role of Social Determinants and Outcomes of Patients with Alcohol-Associated Liver Disease Referred for Early Liver Transplantation: A Multicenter Analysis. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
Donor-Recipient Age Mismatch and Long-Term Graft Outcomes After Adolescent Liver Transplant.
Nakayama, T., Jensen, A. R., Attia, A., Ahn, D. J., Firl, D. J., Kwong, A., … Sasaki, K. (2026). Donor-Recipient Age Mismatch and Long-Term Graft Outcomes After Adolescent Liver Transplant. JAMA Network Open, 9(1), e2552779. -
Use of an electronic health record honest broker to identify and recruit participants at risk for alcohol use disorder
Bowdring, M., Chieng, A., Connors, K., Kwong, A., Mendelson, J., Montgomery, L., … Prochaska, J. (2025). Use of an electronic health record honest broker to identify and recruit participants at risk for alcohol use disorder. ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. WILEY. -
Yttrium-90 radioembolization is associated with a lower risk of liver transplant waitlist dropout than chemoembolization in hepatocellular carcinoma.
Kim, N. G., Yao, F. Y., Kwong, A. J., & Mehta, N. (2026). Yttrium-90 radioembolization is associated with a lower risk of liver transplant waitlist dropout than chemoembolization in hepatocellular carcinoma. Journal of Hepatology. -
Cardiometabolic Risk Factors Impair Recompensation and Survival in Alcohol-Associated Liver Disease.
Torosian, K., Díaz, L. A., Tesfai, K., Wu, W., Cooper, K. M., Devuni, D., … Ajmera, V. (2026). Cardiometabolic Risk Factors Impair Recompensation and Survival in Alcohol-Associated Liver Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. -
Out-of-Sequence or Out of Options? Rethinking Liver Allocation in a Crisis of Confidence.
Attia, A., Sasaki, K., & Kwong, A. J. (2026). Out-of-Sequence or Out of Options? Rethinking Liver Allocation in a Crisis of Confidence. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. -
Successful GH Treatment of Hepatopulmonary Syndrome in Panhypopituitarism-related Advanced Liver Disease.
Chen, S., Diaz-Lankenau, R., Kwong, A., Chang, J., McAvoy, J., & Lai, Y. K. (2026). Successful GH Treatment of Hepatopulmonary Syndrome in Panhypopituitarism-related Advanced Liver Disease. JCEM Case Reports, 4(4), luaf307. -
Spontaneous Recovery and Mortality in Patients with ALD Referred for Early Liver Transplantation.
Hasjim, B. J., Kwong, A. J., Cheung, A., Cooper, K. M., Devuni, D., Mohamed, K., … Lim, N. (2026). Spontaneous Recovery and Mortality in Patients with ALD Referred for Early Liver Transplantation. The American Journal of Gastroenterology.
-
Does it matter what day of the week you have your colonoscopy?
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Liver (Hepatology) Clinic in Redwood City Redwood City, CA
Redwood City, CA
Liver (Hepatology) Clinic in Redwood City
420 Broadway, Pavilion D Fl 2
Redwood City , CA 94063
Make An Appointment More Clinic Information Getting HereLung Transplant Clinic in Palo Alto Palo Alto, CA
Palo Alto, CA
Lung Transplant Clinic in Palo Alto
300 Pasteur Drive, 1st Floor, Suite A11, Ambulatory Care Clinic 1
Palo Alto , CA 94305
Make An Appointment More Clinic Information Getting HereAdvanced Liver Disease Clinic in Redwood City Redwood City, CA
Redwood City, CA
Advanced Liver Disease Clinic in Redwood City
420 Broadway, Pavilion D Fl 2
Redwood City , CA 94063
Make An Appointment More Clinic Information Getting HereLiver Transplant Clinic in Pleasanton Pleasanton, CA
Pleasanton, CA
Liver Transplant Clinic in Pleasanton
5565 W Las Positas Blvd
Pleasanton , CA 94588
Make An Appointment More Clinic Information Getting HereAdvanced Endoscopy in Palo Alto Palo Alto, CA
Palo Alto, CA
Advanced Endoscopy in Palo Alto
300 Pasteur Dr, Ground Fl
Palo Alto , CA 94305
Make An Appointment More Clinic Information Getting HereLiver Transplant Program at Boswell Building Palo Alto, CA
Palo Alto, CA
Liver Transplant Program at Boswell Building
300 Pasteur Dr
Palo Alto , CA 94305
Make An Appointment More Clinic Information Getting HereLiver Transplant Program in Turlock Turlock, CA
Turlock, CA
Liver Transplant Program in Turlock
880 E Tuolumne Rd
Turlock , CA 95382
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Review Summary
Dr. Kwong is consistently described as knowledgeable, professional, and caring. People appreciate her friendly demeanor and the feeling of comfort she creates, making it easier to discuss health concerns. She is regarded as an excellent and helpful doctor, who listens attentively and ensures concerns are addressed. Some value her thoroughness, including following up with colleagues to ensure nothing is missed.
The summary was created by AI, based on recent patient reviews. Learn more
Was this result useful to you?
Patient Reviews
(37 reviews)
Excellent listener and explainer
Helpful and informative
I appreciate Dr Kwong and she explains everything to me in detail. Great Dr!
Dr. Kwong was extremely helpful
I love her, she is an excellent doctor. She has been amazing.
Dr Kwong is excellent!
She was terrific, very knowledgeable. I had a mild panic at first when she started with 'What can I do for you?' since I was not the one who made the appointment with her, I was referred by Dr. Stan Rockson and Dr. Hoffman at Stanford following pre-approval for a TIPS procedure, so I incorrectly assumed she knew why I was calling. I quickly explained my case and it became apparent she had my case notes in front of her and knew enough about my condition and the reason for the referral by Dr. Hoffman to proceed, which was a relief.
Very professional and makes me feel comfortable to address any of my health concerns. She is very knowledgeable and caring.
She’s very greatly appreciated
Stanford is blessed to have Dr. Kwong. She sets the bar
Excellent physician. Grateful to have her as my doctor.
Very nice and knowledgeable about my condition and previous treatments
Dr Kwong listens and answer our concerns. And reminds me what is needed to be done this year.
Allison was friendly and did not rush me throughout my appointment, which is something I really liked. I also appreciated that she stated she was going to follow up with her colleagues to ensure both her and the radiologist did not miss anything that could have been missed.
Enjoyed the consultati
See previous response but very nice and friendly. Asked proper questions to help diagnose the reason I went to see her
Very professional, compassionate and knowledgeable. She makes sure she covers all of my concerns. Very fortunate to have her as my Dr.
Great. Appropriate plan of care
Dr. Kwong was very nice and understanding. Seemed to really care about my health.
Very amazing Doctors
She was friendly and informative.
Dr Kwong answered my questions professionally.
Dr. Kwong was outstanding. Knowledgeable., patience, and very supportive.
Very happy with Dr. Kwang she answered all my concerns.
Facilities are fantastic. Doctor was VERY knowledgeable, informative and professional.
She listened and answered all my questions and concerns.
Very pleasing and informative as should be.
Very compassionate and professional. Dr. Kwong did an incredible job explaining information and answering questions in an accessible way.
She was great to meet my first time and made things understanding as that is what I'm needing now
Thank you for taking the time to listen and the quick follow up to our video visit.
Friendly and listening
She was very pleasant. She smiled almost through the whole video visit. She explained my test results and explained to me what I did not understand. She said she was there if I needed her in the future. The visit made my day! I would give her an A+ on the overall video visit.
Excellent doctor.
Great doc
So far seems good and thorough, thank you.
She is a good doctor
very nice and comfortable. Knowledgeable
View More Patient Reviews
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records